Retro Biosciences

Retro Biosciences is a biotechnology company based in Redwood City, United States, dedicated to developing therapeutics that target the cellular mechanisms of aging. The company aims to extend the healthy human lifespan by 10 years and focuses on preventing and reversing age-related diseases. With a team of 51 to 200 employees, Retro Biosciences is recognized for its innovative approach to longevity treatments. The company specializes in cellular reprogramming, autophagy, and plasma-inspired therapeutics. These areas of focus involve altering cell behavior, recycling damaged cellular components, and exploring novel treatment methods inspired by plasma properties. Retro Biosciences utilizes AI-powered drug development to enhance its research and development processes, collaborating with organizations like OpenAI and Multiply Labs to improve both scientific and manufacturing capabilities. The company has secured significant funding, including a recent $1 billion round, indicating strong financial stability and growth potential.